Ake Borg

发表

Population-based study of the risk of second primary contralateral breast cancer associated with carrying a mutation in BRCA1 or BRCA2.

Hoda Anton-Culver, Colin B Begg, Marinela Capanu, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Intratumor versus intertumor heterogeneity in gene expression profiles of soft‐tissue sarcomas

Patrik Edén, Thomas Breslin, Mef Nilbert, 2005, Genes, chromosomes & cancer.

BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers.

Dong Liang, Patrick Neven, Harvey Risch, 2016, Journal of the National Cancer Institute.

A genomic map of a 6-Mb region at 13q21-q22 implicated in cancer development: identification and characterization of candidate genes

Heli Nevanlinna, Therese Sandberg, Dietrich A. Stephan, 2002, Human Genetics.

Patterns of chromosomal imbalances defines subgroups of breast cancer with distinct clinical features and prognosis. A study of 305 tumors by comparative genomic hybridization.

Jorma Isola, Bo Baldetorp, Å. Borg, 2003, Cancer research.

Breast cancer risk variants at 6 q 25 display different phenotype associations and regulate ESR 1 , RMND 1 and CCDC 170

Wei Zheng, Mads Thomassen, Nicholas A. Sinnott-Armstrong, 2016 .

Distinct sets of gene alterations in endometrial carcinoma implicate alternate modes of tumorigenesis

Mef Nilbert, Å. Borg, P. Bendahl, 2002, Cancer.

BRCA2 mutations in 154 finnish male breast cancer patients.

Anssi Auvinen, A. Auvinen, K. Waltering, 2004, Neoplasia.

Correction: Common Genetic Variants and Modification of Penetrance of BRCA2-Associated Breast Cancer

Joshua M. Korn, Christiana Kartsonaki, Amanda B. Spurdle, 2010, PLoS Genetics.

PIK3CA mutations correlate with hormone receptors, node metastasis, and ERBB2, and are mutually exclusive with PTEN loss in human breast carcinoma.

Hanina Hibshoosh, Xiaomei Wang, Matthew Maurer, 2005, Cancer research.

Human neuroblastoma cells exposed to hypoxia: induction of genes associated with growth, survival, and aggressive behavior.

Johan Vallon-Christersson, Å. Borg, J. Vallon-Christersson, 2004, Experimental cell research.

RAD50 and NBS1 are breast cancer susceptibility genes associated with genomic instability.

Arto Mannermaa, Robert Winqvist, Sakari Knuutila, 2005, Carcinogenesis.

Endothelial Induced EMT in Breast Epithelial Cells with Stem Cell Properties

Markus Ringnér, Magnus K. Magnusson, Thorarinn Gudjonsson, 2011, PloS one.

Common breast cancer susceptibility alleles and the risk of breast cancer for BRCA1 and BRCA2 mutation carriers: implications for risk prediction.

Mads Thomassen, Etienne Rouleau, Dieter Niederacher, 2010, Cancer research.

Inheritance of deleterious mutations at both BRCA1 and BRCA2 in an international sample of 32,295 women

Olufunmilayo I. Olopade, Mads Thomassen, Dieter Niederacher, 2016, Breast Cancer Research.

Predicting continuous values of prognostic markers in breast cancer from microarray gene expression profiles.

Carsten Peterson, Patrik Edén, Mårten Fernö, 2004, Molecular cancer therapeutics.

Identification of subtypes in human epidermal growth factor receptor 2--positive breast cancer reveals a gene signature prognostic of outcome.

Johan Staaf, Mårten Fernö, Markus Ringnér, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Association of Genomic Domains in BRCA1 and BRCA2 with Prostate Cancer Risk and Aggressiveness.

Stefania Tommasi, Laura Cortesi, Mads Thomassen, 2019, Cancer research.